Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001615219-22-000018)

Filing Details

Accession Number:: 0001615219-22-000018
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-03-09 16:01:55
Reporting Period:: 2022-03-03

Accepted Time:: 2022-03-09 16:01:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1615219	Salarius Pharmaceuticals Inc.	SLRX	Pharmaceutical Preparations (2834)	465087339

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1769331	J. David Arthur	C/O Salarius Pharmaceuticals, Inc. 2450 Holcome Blvd., Suite X Houston TX 77021	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-03-03	139,488	$0.39	249,674	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The Registrant issued these shares to the reporting person as part of his bonus; which shares were issued in lieu of net cash compensation. The shares were issued at the fair market value of the Registrants common stock on the date of grant.